Cambridge and Oxford team up to pitch investment opportunities
The first ever event for investors to learn about prospective spin-out companies from both the Universities of Oxford and Cambridge was held at the London Stock Exchange last week.
PhoreMost raises £2.5m to identify new druggable targets for therapeutics
PhoreMost Ltd, a biopharmaceutical company and University of Cambridge spin-out founded to identify new druggable targets for cancer and other unmet diseases, announced that it has raised £2.5 million in seed funding from Cambridge-based investors: Jonathan Milner, Amadeus Capital, Sunil Shah and Prashant Shah (O2H Ventures), Cambridge Enterprise, and Dr Chris Torrance, PhoreMost’s CEO.
Jukedeck wins Pitch@Palace 3.0
University start-up Jukedeck, founded by Faculty of Music graduate Ed Rex, won big this week at Pitch@Palace 3.0, an event spearheaded by HRH The Duke of York to identify the most promising technology start-ups.
University spin-out Enval demonstrates aluminium recovery technology in recycling trials
Enval’s pioneering technology will provide the recycling solution for a project to assess the feasibility of including flexible laminate packaging, such as food and drink pouches, pet food pouches and toothpaste tubes, in existing household recycling schemes.
University spin-out XO1 acquired by Janssen
University of Cambridge spin-out XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab, has been acquired by Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Financial terms of the transaction have not been disclosed
Sphere Fluidics named one of Britain's most disruptive businesses
Cambridge Enterprise portfolio company Sphere Fluidics has been named one of the UK's top 50 disruptive SMEs by Real Business.
ilumink, leader in printable laser technology, acquired by Tracerco
University spin-out ilumink has been acquired by leading industrial technology specialist Tracerco, part of the Johnson Matthey group.
Automated sample cleaning technology developed to simplify prep, improve reliability
A new, automated cleaning system for geological samples that simplifies their preparation and improves sample reliability has been developed by a team of University of Cambridge researchers.
Dr Paul J. Seabright appointed Cambridge Enterprise Deputy Director
Dr Paul J. Seabright, Head of Cambridge Enterprise (CE) Consultancy Services, has been appointed the University knowledge transfer company’s new Deputy Director. He replaces Dr Richard Jennings, who will retire from the post in March.
Dr Geraldine Rodgers, former head of Cambridge Enterprise Seed Funds, dies
Dr Geraldine Rodgers, an early, driving force of University investment support for spin-out companies, has died from lung cancer. She was 66.
Richard Jennings, Cambridge Enterprise Deputy Director, announces retirement
Dr Richard Jennings, a UK pioneer in the field of academic knowledge transfer, will in March step down as Deputy Director of Cambridge Enterprise (CE), the commercialisation arm of the University of Cambridge.
Fluidic Analytics secures £1.56 million to develop new protein characterisation technology
Fluidic Analytics Limited, a spin-out from the University of Cambridge, has raised £1.56 million (US$2.4 million) in a Series A financing led by Cambridge Enterprise and including DFJ Esprit, IQ Capital, Parkwalk Advisors and Amadeus Capital Partners as co-investors.
Aqdot closes £2.55m funding round
Aqdot, a specialist chemical company originally spun out of the University of Cambridge with a focus in intelligent encapsulation, has completed a £2.55m oversubscribed funding round.
Jukedeck wins LeWeb Start-up Competition
Jukedeck, a University of Cambridge start-up that offers computer-generated music to accompany on-line games and YouTube videos, has been awarded first place in the LeWeb Start-up Competition.
Where there’s muck there’s aluminium
Technology developed at the University of Cambridge lies at the heart of a commercial process that can turn toothpaste tubes and drinks pouches into both aluminium and fuel in just three minutes.
Cambridge academics are winners in GSK’s Discovery Fast Track Challenge
Three University of Cambridge projects have been selected as winners in GSK’s 2014 Discovery Fast Track Challenge, which is designed to accelerate the translation of academic research into novel therapies.
FDA approves MS drug developed by University of Cambridge researchers
The US Food and Drug Administration (FDA) has approved Lemtrada(TM) (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS), Sanofi and its subsidiary Genzyme have announced.
Lynparza recommended for approval in ovarian cancer
The European Medicines Agency (EMA) has recommended granting AstraZeneca marketing authorisation for Lynparza (olaparib), a first-in-class medicine for the treatment of women with a subtype of ovarian cancer for which there are limited approved treatment options.
Bridging the knowledge transfer divide: fill out a quick survey to help Cambridge Enterprise
The difficulty in translating university research into the commercial realm is a well-documented problem. The reason is often that industry and academia are driven by different motivations related to their fundamentally distinct core.
New Cambridge Enterprise office opens on University Biomedical Campus
Cambridge Enterprise, the University’s commercialisation arm, is expanding its reach with the opening of an adjunct office on the first floor of the University’s School of Clinical Medicine, providing a base on the Addenbrooke’s site for the Cambridge Enterprise Life Sciences team.
Inivata raises £4m to improve cancer treatment through simple blood tests
Inivata, a clinical cancer genomics company focused on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment, today announced it has raised £4m in a funding round led by Imperial Innovations and including Cambridge Innovation Capital and Johnson & Johnson Development Corporation.
Breathing Buildings CEO named Fellow of Royal Academy of Engineering
Breathing Buildings CEO Shaun Fitzgerald has been elected a Fellow of The Royal Academy of Engineering.
Scientists reset human stem cells to earliest developmental state
Scientists have successfully ‘reset’ human pluripotent stem cells to the earliest developmental state – equivalent to cells found in an embryo before it implants in the womb (7-9 days old). These ‘pristine’ stem cells may mark the true starting point for human development, but have until now been impossible to replicate in the lab
Another record year for University of Cambridge spin-out investments
The University of Cambridge has broken its early stage investment record for a second year running, approving nine seed fund investments for a total of £2.7 million, an increase on the £2.3 million invested in 2012/13.
Generative music start-up Jukedeck raises £500K in investment funding
Jukedeck, a University of Cambridge start-up developing software aimed at transforming the world of digital music composition, has raised £500K in investment funding. The round is being led by Cambridge Enterprise, the commercialisation arm of the University of Cambridge, with Cambridge Innovation Capital and the University EIS Fund participating.